Targeted Oncology,volume 3,issue 4  (10-2013)

Period of time： 2013年4期

Publisher： Springer Publishing Company

Founded in： 2006

Total resources： 10

ISSN： 1776-2596

Subject： R73 Oncology

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Targeted Oncology,volume 3,issue 4

Menu

Predictive markers for anti-EGFR antibodies in colorectal cancer: the beginning of a new era

By Van Cutsem Eric in (2008)

Targeted Oncology,volume 3,issue 4 , Vol. 3, Iss. 4, 2008-10 , pp. 223-225

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Functional inactivation of CD4+CD25 high regulatory T cells using low dose human/mouse chimeric anti-CD25 monoclonal antibody enhanced lymphokine-activated killer cells activity

By Okita Riki in (2008)

Targeted Oncology,volume 3,issue 4 , Vol. 3, Iss. 4, 2008-10 , pp. 227-234

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Mechanisms of resistance to EGFR tyrosine kinase inhibitors: implications for patient selection and drug combination strategies

By Eyzaguirre Alexandra in (2008)

Targeted Oncology,volume 3,issue 4 , Vol. 3, Iss. 4, 2008-10 , pp. 235-243

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Management of skin toxicity of epidermal growth factor receptor inhibitors

By Segaert Siegfried in (2008)

Targeted Oncology,volume 3,issue 4 , Vol. 3, Iss. 4, 2008-10 , pp. 245-251

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Complete pathological response of colorectal liver metastases after chemotherapy and bevacizumab treatment: a case report

By Vitiello F. in (2008)

Targeted Oncology,volume 3,issue 4 , Vol. 3, Iss. 4, 2008-10 , pp. 253-258

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Successful treatment of brain metastases from renal cell cancer using radiotherapy in combination with sorafenib

By Stierner Ulrika in (2008)

Targeted Oncology,volume 3,issue 4 , Vol. 3, Iss. 4, 2008-10 , pp. 259-264

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Plasma cell leukemia: advantages of treatment with bortezomib

By Fraimout N. in (2008)

Targeted Oncology,volume 3,issue 4 , Vol. 3, Iss. 4, 2008-10 , pp. 265-267

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Total 7 item(s)